These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24324289)

  • 1. Rheumatoid factors: clinical applications.
    Ingegnoli F; Castelli R; Gualtierotti R
    Dis Markers; 2013; 35(6):727-34. PubMed ID: 24324289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
    Elshafie AI; Elbagir S; Aledrissy MIE; Elagib EM; Nur MAM; Rönnelid J
    Clin Rheumatol; 2019 Jun; 38(6):1545-1553. PubMed ID: 30656490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
    Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis.
    Das H; Atsumi T; Fukushima Y; Shibuya H; Ito K; Yamada Y; Amasaki Y; Ichikawa K; Amengual O; Koike T
    Clin Rheumatol; 2004 Jun; 23(3):218-22. PubMed ID: 15168148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
    Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
    Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases.
    Dubucquoi S; Solau-Gervais E; Lefranc D; Marguerie L; Sibilia J; Goetz J; Dutoit V; Fauchais AL; Hachulla E; Flipo RM; Prin L
    Ann Rheum Dis; 2004 Apr; 63(4):415-9. PubMed ID: 15020336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
    Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
    Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
    Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
    Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis.
    Bos WH; van de Stadt LA; Sohrabian A; Rönnelid J; van Schaardenburg D
    Arthritis Res Ther; 2014; 16(2):405. PubMed ID: 25167340
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical informativeness of detection of antibodies to citrullinated proteins under rheumatoid arthritis].
    Cherkasova MV; Novikov AA; Alexndrova EN; Karateev DE; Popkova TV; Luchikhina EL; Avdeeva AS; Nasonov EL
    Klin Lab Diagn; 2015 Feb; 60(2):46-9. PubMed ID: 26027260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.
    Nishimura K; Sugiyama D; Kogata Y; Tsuji G; Nakazawa T; Kawano S; Saigo K; Morinobu A; Koshiba M; Kuntz KM; Kamae I; Kumagai S
    Ann Intern Med; 2007 Jun; 146(11):797-808. PubMed ID: 17548411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
    Brickmann K; Brezinschek RI; Yazdani-Biuki B; Graninger WB; Brezinschek HP
    Clin Exp Rheumatol; 2010; 28(6):888-91. PubMed ID: 21205465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests.
    Infantino M; Manfredi M; Meacci F; Sarzi-Puttini P; Ricci C; Atzeni F; Benucci M
    Clin Chim Acta; 2014 Sep; 436():237-42. PubMed ID: 24892812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.